Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16,417 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large-scale multicenter retrospective study.
Fujii H, Suzuki Y, Sawada K, Tatsuta M, Maeshiro T, Tobita H, Tsutsumi T, Akahane T, Hasebe C, Kawanaka M, Kessoku T, Eguchi Y, Syokita H, Nakajima A, Kamada T, Yoshiji H, Kawaguchi T, Sakugawa H, Morishita A, Masaki T, Ohmura T, Watanabe T, Kawada N, Yoda Y, Enomoto N, Ono M, Fuyama K, Okada K, Nishimoto N, Ito YM, Kamada Y, Takahashi H, Sumida Y; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Fujii H, et al. Among authors: suzuki y. Hepatol Res. 2023 Nov;53(11):1059-1072. doi: 10.1111/hepr.13947. Epub 2023 Aug 28. Hepatol Res. 2023. PMID: 37537735
α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C.
Asahina Y, Tsuchiya K, Nishimura T, Muraoka M, Suzuki Y, Tamaki N, Yasui Y, Hosokawa T, Ueda K, Nakanishi H, Itakura J, Takahashi Y, Kurosaki M, Enomoto N, Nakagawa M, Kakinuma S, Watanabe M, Izumi N. Asahina Y, et al. Among authors: suzuki y. Hepatology. 2013 Oct;58(4):1253-62. doi: 10.1002/hep.26442. Epub 2013 Aug 19. Hepatology. 2013. PMID: 23564522
Prospective comparison of real-time tissue elastography and serum fibrosis markers for the estimation of liver fibrosis in chronic hepatitis C patients.
Tamaki N, Kurosaki M, Matsuda S, Nakata T, Muraoka M, Suzuki Y, Yasui Y, Suzuki S, Hosokawa T, Nishimura T, Ueda K, Tsuchiya K, Nakanishi H, Itakura J, Takahashi Y, Matsunaga K, Taki K, Asahina Y, Izumi N. Tamaki N, et al. Among authors: suzuki y, suzuki s. Hepatol Res. 2014 Jul;44(7):720-7. doi: 10.1111/hepr.12179. Epub 2013 Jul 10. Hepatol Res. 2014. PMID: 23742243
Hepatic Amyloidosis with an Extremely High Stiffness Value on Magnetic Resonance Elastography.
Matsuda S, Motosugi U, Kato R, Muraoka M, Suzuki Y, Sato M, Shindo K, Nakayama Y, Inoue T, Maekawa S, Sakamoto M, Enomoto N. Matsuda S, et al. Among authors: suzuki y. Magn Reson Med Sci. 2016 Jul 11;15(3):251-2. doi: 10.2463/mrms.ci.2015-0133. Epub 2016 Mar 21. Magn Reson Med Sci. 2016. PMID: 27001387 Free PMC article. No abstract available.
Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinoma.
Suzuki Y, Maekawa S, Komatsu N, Sato M, Tatsumi A, Miura M, Matsuda S, Muraoka M, Nakakuki N, Shindo H, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Inoue T, Sato T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N. Suzuki Y, et al. Hepatol Res. 2019 Jan;49(1):51-63. doi: 10.1111/hepr.13277. Epub 2018 Dec 27. Hepatol Res. 2019. PMID: 30350374
Cancer-related genetic changes in multistep hepatocarcinogenesis and their correlation with imaging and histological findings.
Muraoka M, Maekawa S, Suzuki Y, Sato M, Tatsumi A, Matsuda S, Miura M, Nakakuki N, Shindo H, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Inoue T, Sato T, Yamashita A, Moriishi K, Matsuda M, Enomoto N. Muraoka M, et al. Among authors: suzuki y. Hepatol Res. 2020 Sep;50(9):1071-1082. doi: 10.1111/hepr.13529. Epub 2020 Jun 30. Hepatol Res. 2020. PMID: 32510681
Deep sequencing analysis of serum hepatitis B virus-RNA during nucleot(s)ide analogue therapy.
Matsuda S, Maekawa S, Komiyama Y, Nakakuki N, Muraoka M, Suzuki Y, Sato M, Tatsumi A, Miura M, Amemiya F, Shindo H, Takano S, Fukasawa M, Yamaguchi T, Nakayama Y, Inoue T, Sato T, Yamashita A, Moriishi K, Enomoto N. Matsuda S, et al. Among authors: suzuki y. Hepatol Res. 2021 Jan;51(1):39-50. doi: 10.1111/hepr.13574. Epub 2021 Jan 11. Hepatol Res. 2021. PMID: 32961003
Significance of serum IP-10/CXCL10 measurement in predicting post-direct acting antiviral treatment liver function in patients with HCV-decompensated liver cirrhosis.
Katoh R, Maekawa S, Osawa L, Komiyama Y, Nakakuki N, Takada H, Matsuda S, Muraoka M, Suzuki Y, Sato M, Tatsumi A, Takano S, Fukasawa M, Yamaguchi T, Nakayama Y, Inoue T, Enomoto N. Katoh R, et al. Among authors: suzuki y. Hepatol Res. 2023 Apr;53(4):280-288. doi: 10.1111/hepr.13861. Epub 2022 Dec 13. Hepatol Res. 2023. PMID: 36445119
16,417 results
You have reached the last available page of results. Please see the User Guide for more information.